Interaction of prostaglandin A2 with vascular smooth muscle tone and contractility.
D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000378:metabolism; D001464:Barium / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002132:Calcium Radioisotopes; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects / Q000378:metabolism; D008642:Mesenteric Veins / Q000187:drug effects / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects*; D009129:Muscle Tonus / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D012501:Saphenous Vein / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
D002132:Calcium Radioisotopes; D011453:Prostaglandins; D001464:Barium; D011189:Potassium Chloride; D002118:Calcium; D009638:Norepinephrine